A Rationally Designed Bimetallic Platinum (II)‐Ferrocene Antitumor Agent Induces Non‐Apoptotic Cell Death and Exertsin VivoEfficacy
- 30 June 2022
- journal article
- research article
- Published by Wiley in Chemistry – A European Journal
- Vol. 28 (46) , e202201259
Abstract
Despite phenomenal clinical success, the efficacy of platinum anticancer drugs is often compromised due to inherent and acquired drug resistant phenotypes in cancers. To circumvent this issue, we designed two heterobimetallic platinum (II)‐ferrocene hybrids that display multi‐pronged anticancer action. In cancer cells, our best compound,2, platinates DNA, produces reactive oxygen species, and has nucleus, mitochondria, and endoplasmic reticulum as potential targets. The multi‐modal mechanism of action of these hybrid agents lead to non‐apoptotic cell death induction which enables circumventing apoptosis resistance and significant improvement in platinum cross resistance profile. Finally, in addition to describing detail mechanistic insights, we also assessed its stability in plasma and demonstrate anticancer efficacy in an in vivo A2780 xenograft model. Strikingly, compared to oxaliplatin, our compound displays better tolerability, safety profile and efficacy in vivo.Keywords
Funding Information
- Tata Institute of Fundamental Research (RTI4003)
This publication has 63 references indexed in Scilit:
- Shikonin Kills Glioma Cells through Necroptosis Mediated by RIP-1PLOS ONE, 2013
- Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic ChangesPharmacological Reviews, 2012
- In Vitro Anticancer Activity ofcis-Diammineplatinum(II) Complexes with β-Diketonate Leaving Group LigandsJournal of Medicinal Chemistry, 2012
- Aminoferrocene-Based Prodrugs Activated by Reactive Oxygen SpeciesJournal of Medicinal Chemistry, 2012
- Mitochondrial-targeted fluorescent probes for reactive oxygen speciesCurrent Opinion in Chemical Biology, 2010
- Intermetallic Communication in Titanium(IV) FerrocenyldiketonatesInorganic Chemistry, 2009
- Rare-Earth Complexes of Ferrocene-Containing Ligands: Visible-Light Excitable Luminescent MaterialsInorganic Chemistry, 2007
- Organic Cation Transporters Are Determinants of Oxaliplatin CytotoxicityCancer Research, 2006
- Hypoxia-Mediated Down-Regulation of Bid and Bax in Tumors Occurs via Hypoxia-Inducible Factor 1-Dependent and -Independent Mechanisms and Contributes to Drug ResistanceMolecular and Cellular Biology, 2004
- Death and anti-death: tumour resistance to apoptosisNature Reviews Cancer, 2002